Description
BLOOD&BLOOD RELATED PRODUCTS&SERVICES
First action · last action
2024-10-01 · 2026-01-26
Transactions
2
First transaction's obligation
$24,862
Base + all options value (sum of deltas)
$6,152
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25621D0010
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-10-01+$24,862= $24,862
- Mod P000012026-01-26-$18,710= $6,152
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-10-01 | +$24,862 | $24,862 | BLOOD&BLOOD RELATED PRODUCTS&SERVICES |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2026-01-26 | −$18,710 | $6,152 | BLOOD&BLOOD RELATED PRODUCTS&SERVICES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PNAEF6YNHFY4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626N0209 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $71,646 | FY2026 |
| 36C25626D0127 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C25626N0210 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $239,128 | FY2026 |
| 36C24926N0133 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $390,791 | FY2026 |
| 36C24925N0158 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $162,074 | FY2025 |
| 36C25625N0105 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $144,871 | FY2025 |
Other recipients under 6550 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626P0524 | ROCHE DIAGNOSTICS CORPORATION | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $134,375 | FY2026 |
| 36C25626N0450 | THE BLOOD CENTER | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $324,605 | FY2026 |
| 36C25626D0050 | THE BLOOD CENTER | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
| 36C25626N0432 | THE BLOOD CENTER | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $245,189 | FY2026 |
| 36C25626N0413 | TOSOH BIOSCIENCE, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $32,760 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25625N0078_3600_36C25621D0010_3600 · retrieved 2026-09-26.